Navigation Links
Drugs found to both prevent and treat Alzheimer's disease in mice
Date:5/21/2013

Researchers at USC have found that a class of pharmaceuticals can both prevent and treat Alzheimer's Disease in mice.

The drugs, known as "TSPO ligands," are currently used for certain types of neuroimaging.

"We looked at the effects of TSPO ligand in young adult mice when pathology was at an early stage, and in aged mice when pathology was quite severe," said lead researcher Christian Pike of the USC Davis School of Gerontology. "TSPO ligand reduced measures of pathology and improved behavior at both ages."

The team's findings were published online by the Journal of Neuroscience on May 15. Pike's coauthors include USC postdoctoral scientists Anna M. Barron, Anusha Jayaraman and Joo-Won Lee; as well as Donatella Caruso and Roberto C. Melcangi of the University of Milan and Luis M. Garcia-Segura of the Instituto Cajal in Spain.

The most surprising finding for Pike and his team was the effect of TSPO ligand in the aged mice. Four treatmentsonce per week over four weeksin older mice resulted in a significant decrease of Alzheimer's-related symptoms and improvements in memory meaning that TSPO ligands may actually reverse some elements of Alzheimer's disease.

"Our data suggests the possibility of drugs that can prevent and treat Alzheimer's," Pike said. "It's just mouse data, but extremely encouraging mouse data. There is a strong possibility that TSPO ligands similar to the ones used in our study could be evaluated for therapeutic efficacy in Alzheimer's patients within the next few years."

Next, the team will next focus on understanding how TSPO ligands reduce Alzheimer's disease pathology. Building on the established knowledge that TSPO ligands can reduce inflammationshielding nerve cells from injury and increasing the production of neuroactive hormones in the brainthe team will study which of these actions is the most significant in fighting Alzheimer's disease so they can develop newer TSPO ligands accordingly.


'/>"/>

Contact: Robert Perkins
perkinsr@usc.edu
213-740-9226
University of Southern California
Source:Eurekalert

Related biology news :

1. Renaissance in new drugs for rare diseases
2. Renaissance in new drugs for rare diseases: Report in worlds largest scientific socity magazine
3. How do anticancer drugs work?
4. Mapping of cancer cell fuel pumps paves the way for new drugs
5. Co-Q10 deficiency may relate to concern with statin drugs, higher risk of diabetes
6. Cholesterol rafts deliver drugs inside cancer cells
7. Findings to help in design of drugs against virus causing childhood illnesses
8. KU Leuven lab coordinates €9m effort to find new deep-sea drugs
9. Mood-modifying drugs for humans also alter fish behavior
10. Study finds potential to match tumors with known cancer drugs
11. £6.5M in funding to help manufacture the drugs of the future
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2016)...   IdentyTechSolutions America LLC , a leading ... and a cutting-edge manufacturer of software and hardware ... seamless, integrated solutions that comprise IDT biometric readers ... provide IdentyTech,s customers with combined physical identification and ... and theft. "We are proud to ...
(Date:12/16/2016)... 2016 The global wearable medical device market, in terms ... from USD 5.31 billion in 2016, at a CAGR of 18.0% ... ... advancements in medical devices, launch of a growing number of smartphone-based ... among healthcare providers, and increasing focus on physical fitness. ...
(Date:12/15/2016)... Calif. , Dec. 15, 2016   WaferGen ... publicly held genomics technology company, announced today that on ... Listing Qualifications Department of The Nasdaq Stock Market LLC ... closing bid price of WaferGen,s common stock had been ... Accordingly, WaferGen has regained compliance with Listing Rule 5550(a)(2) ...
Breaking Biology News(10 mins):
(Date:1/16/2017)... 2017   Valentin A. Pavlov, PhD , associate ... and CEO of The Feinstein Institute for Medical ... how the nervous system regulates the immune system, which ... medicine devices to treat disease and injury. The ... The paper examines various studies which further ...
(Date:1/16/2017)... Jan. 16, 2017  Eurofins Genomics today announced the ... more customers to receive their primers in a shorter ... in quality found with other providers. Express oligos are ... at no additional fee. Researchers ... studies, including DNA sequencing, genotyping, site-directed mutagenesis, and cloning. ...
(Date:1/14/2017)... -- The Alliance for Safe Biologic Medicines (ASBM) today issued ... guidance on biologic naming: We commend ... importance of distinct naming for all biologics, including biosimilars. ... will bring to patients, including new treatment options and ... the Guidance dealing with suffix design remains at odds ...
(Date:1/13/2017)... Research and Markets has announced the addition of ... ... grow at a CAGR of 16.83% during the period 2017-2021. ... the global biopolymers market for 2017-2021. To calculate the market size, the ... products. The report also includes a a discussion of the key vendors ...
Breaking Biology Technology: